Fund Holdings — Indaba Capital Management, L.P.

Total Portfolio Value:
$166.60M
Total Bought:
$20.04M
Total Sold:
$43.65M
Net Transaction:
-$23.61M
Notable People:
Derek Christopher Schrier, Ic Gp, Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Bandwidth Inc.NOTE 0 500 4 0(BAND)000$32.17M$32.48M19.50%+$313.9K
Summit Hotel Properties, Inc.NOTE 1 500 2 1(INN)000$21.97M$27.79M16.68%+$5.83M
On24 Inc
COM
4,240,2564,240,2560$27.39M$22.05M13.23%-$5.34M
Accelerate Diagnostics IncNOTE 5 000 12 1000$12.34M$18.52M11.12%+$6.18M
Ironwood Pharmaceuticals, Inc.NOTE 1 500 6 1(IRWD)000$13.04M$15.08M9.05%+$2.05M
Equity ComwlthCOM SH BEN INT9,550,0008,403,411-1,146,589$16.90M$13.53M8.12%-$3.37M
Travere Therapeutics IncNOTE 2 500 9 1000$12.83M$12.78M7.67%-$49.4K
Blackbaud, Inc.(BLKB)0193,000+193,000$0$11.98M7.19%+$11.98M
Esperion Therapeutics Inc Ne3,000,0003,000,0000$6.60M$4.32M2.59%-$2.28M
Atlanta Braves Hldgs IncCOM SER C093,811+93,811$0$3.75M2.25%+$3.75M
Embecta Corp.(EMBC)0221,938+221,938$0$2.83M1.70%+$2.83M
Advantage Solutions Inc.CL A(ADV)0980,865+980,865$0$1.48M0.89%+$1.48M
Blue Owl Cap Corp Iii2,793,3660-2,793,366$40.28M$0—-$40.28M
Revance Therapeutics IncNOTE 1 750 2 1000$24.03M$0—-$24.03M
Page 1 of 1
Indaba Capital Management, L.P. — 13F Holdings — Q1 2025 | TickerTrail